SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-047965
Filing Date
2024-05-30
Accepted
2024-05-30 16:05:11
Documents
14
Period of Report
2024-05-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0207083-8k_china.htm   iXBRL 8-K 26408
2 AMENDMENT #2 TO CONVERTIBLE PROMISSORY NOTE DATED MAY 23, 2024 ea020708301ex10-1_china.htm EX-10.1 20804
  Complete submission text file 0001213900-24-047965.txt   228987

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE cphi-20240523.xsd EX-101.SCH 3048
4 XBRL LABEL FILE cphi-20240523_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE cphi-20240523_pre.xml EX-101.PRE 22381
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0207083-8k_china_htm.xml XML 3779
Mailing Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216
Business Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216 8689866811730
CHINA PHARMA HOLDINGS, INC. (Filer) CIK: 0001106644 (see all company filings)

IRS No.: 731564807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34471 | Film No.: 241005164
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)